Literature DB >> 23026614

Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.

E C de Ataide1, M Garcia, T J A P Mattosinho, J R S Almeida, C A F Escanhoela, I F S F Boin.   

Abstract

BACKGROUND: Liver transplantation is a controversial issue in the initial management of hepatocellular carcinoma (HCC). The aim of this study was to demonstrate that up-to-seven could be useful as a model in evaluating potential candidates for liver transplantation for HCC.
METHODS: Between January 1997 and December 2010, 84 patients undergoing liver transplantation were analyzed for HCC. Pathologic variables included the number of lesions, maximal tumor diameter, vascular invasion, and tumor grade. The following variables were recorded: Age, gender, recurrence of HCC, survival, donor age, incidental, Milan criteria, Model for End-Stage Liver Disease score, and alpha-fetoprotein (AFP) levels. To evaluate variables we used the Kaplan-Meier method, Cox regression and Kolmogorov-Smirnov test.
RESULTS: There were 68 (80.9%) patients within up-to-seven criteria and 16 (19.1%) beyond this criteria. AFP levels were 96.4 versus 464.3 ng/dL in patients within versus beyond up-to-seven criteria. The median diameter of the largest nodule was 22.2 versus 32.0 mm in patients within versus beyond up-to-seven criteria, respectively. The median sum of nodules was 1.8 and 5.6 nodules in patients within versus beyond up-to-seven criteria. Vascular invasion was present in 11 (13.0%) patients within versus 7 (8.3%) beyond. Recurrence was observed in 9 (10.7%) patients and only 3 were beyond up-to-seven criteria, 2 had vascular invasion, and another showed poor differentiation. Post liver transplantation survival rates were 87.7%, 74.5%, and 65.3% at 1, 3, and 5 years in patients within up-to-seven versus 80.7%, 51.7%, and 32.1% beyond (P = .03). Similar results were observed when we applied Milan criteria or expanded Milan criteria. The largest nodule was the only predictive factor after proportional hazard Cox regression application (Beta = 0.037; exponent = 1.0377; Wald = 4.542; P = .03). In the present study, up-to-seven criteria could be useful to evaluate potential liver transplant candidates due to HCC.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026614     DOI: 10.1016/j.transproceed.2012.07.006

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

Authors:  Michał Grąt; Oskar Kornasiewicz; Zbigniew Lewandowski; Wacław Hołówko; Karolina Grąt; Konrad Kobryń; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 2.  Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation.

Authors:  Marta Guerrero-Misas; Manuel Rodríguez-Perálvarez; Manuel De la Mata
Journal:  World J Hepatol       Date:  2015-04-08

Review 3.  Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

Authors:  Kyung-Suk Suh; Hae Won Lee
Journal:  Hepat Oncol       Date:  2015-01-12

4.  Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization.

Authors:  Antonio Orlacchio; Fabrizio Chegai; Stefano Merolla; Simona Francioso; Costantino Del Giudice; Mario Angelico; Giuseppe Tisone; Giovanni Simonetti
Journal:  World J Hepatol       Date:  2015-06-28

5.  Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis.

Authors:  Jian-Yong Lei; Wen-Tao Wang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

6.  The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.

Authors:  Michał Grąt; Karolina M Wronka; Jan Stypułkowski; Emil Bik; Maciej Krasnodębski; Łukasz Masior; Zbigniew Lewandowski; Karolina Grąt; Waldemar Patkowski; Marek Krawczyk
Journal:  Ann Surg Oncol       Date:  2016-08-16       Impact factor: 5.344

7.  Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation.

Authors:  Christin Bürger; Miriam Maschmeier; Anna Hüsing-Kabar; Christian Wilms; Michael Köhler; Martina Schmidt; Hartmut H Schmidt; Iyad Kabar
Journal:  Can J Gastroenterol Hepatol       Date:  2019-01-08

Review 8.  Expanding Indications for Liver Transplant: Tumor and Patient Factors.

Authors:  Kevin Ka-Wan Chu; Kelly Hiu-Ching Wong; Kenneth Siu-Ho Chok
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

9.  Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis.

Authors:  Vladimir J Lozanovski; Ali Ramouz; Ehsan Aminizadeh; Sadeq Ali-Hasan Al-Saegh; Elias Khajeh; Heike Probst; Susanne Picardi; Christian Rupp; De-Hua Chang; Pascal Probst; Arianeb Mehrabi
Journal:  BJS Open       Date:  2022-01-06

10.  Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma.

Authors:  Luciana Dos Santos Schraiber; Angelo Alves de Mattos; Maria Lucia Zanotelli; Guido Pio Cracco Cantisani; Ajácio Bandeira de Mello Brandão; Cludio Augusto Marroni; Guilhermo Kiss; Lucas Ernani; Patrícia Dos Santos Marcon
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.